Filing Details
- Accession Number:
- 0001062993-25-001617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-04 16:11:53
- Reporting Period:
- 2025-01-31
- Accepted Time:
- 2025-02-04 16:11:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1455365 | Cognition Therapeutics Inc | CGTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1418200 | Lisa Ricciardi | C/O Cognition Therapeutics Inc 2500 Westchester Avenue Purchase NY 10577 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-01-31 | 38,851 | $0.77 | 38,851 | No | 4 | P | Indirect | By Spouse |
Common Stock | Disposition | 2025-02-03 | 28,960 | $0.67 | 262,385 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2025-02-04 | 631,300 | $0.00 | 893,685 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Spouse |
No | 4 | F | Direct | |
No | 4 | A | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7602 to $0.7816, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- Each share is represented by an RSU. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.